The glycoprotein precursor gene of Junin virus determines the virulence of the romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever

Journal of Virology

Volumn 89, Issue 11, 2015, Pages 5949-5956

  Seregin, Alexey V ^a,b   Yun, Nadezhda E ^a,b   Miller, Milagros ^a,b   Aronson, Judith ^a   Smith, Jennifer K ^a   Walker, Aida G ^a,b   Smith, Jeanon N ^a,b   Huang, Cheng ^a,b   Manning, John T ^a,b   de la Torre, Juan C ^c   Paessler, Slobodan ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGENTINE HEMORRHAGIC FEVER; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GP2 GENE; GUINEA PIG; IN VITRO STUDY; JUNIN VIRUS; NONHUMAN; PRIORITY JOURNAL; REVERSE GENETICS; VIRUS ATTENUATION; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; AMERICAN HEMORRHAGIC FEVER; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMALIA; ARENAVIRUS; CANDIDA; CAVIA; JUNIN VIRUS; MUS;

GLYCOPROTEIN; VIRULENCE FACTOR; VIRUS ENVELOPE PROTEIN;

ANIMALS; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; GUINEA PIGS; HEMORRHAGIC FEVER, AMERICAN; JUNIN VIRUS; REVERSE GENETICS; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRULENCE FACTORS;

EID: 84929630617     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00104-15     Document Type: Article

References (26)

1. Elsner B, Schwarz E, Mando OG, Maiztegui J, Vilches A. 1973. Pathology of 12 fatal cases of Argentine hemorrhagic fever. Am J Trop Med Hyg 22:229-236.
2. Molinas FC, Kordich L, Porterie P, Lerer G, Maiztegui JI. 1987. Plasminogen abnormalities in patients with argentine hemorrhagic fever. Thrombosis Res 48:713-720. http://dx.doi.org/10.1016/0049-3848(87)90436-1.
3. Marta RF, Montero VS, Molinas FC. 1998. Systemic disorders in Argentine haemorrhagic fever. Bulletin de l'Institut Pasteur 96:115-124.
4. Molinas FC, de Bracco MME, Maiztegui JI. 1981. Coagulation studies in Argentine hemorrhagic fever. J Infect Dis 143:1-6. http://dx.doi.org/10.1093/infdis/143.1.1.
5. Yun NE, Linde NS, Dziuba N, Zacks MA, Smith JN, Smith JK, Aronson JF, Chumakova OV, Lander HM, Peters CJ, Paessler S. 2008. Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am J Trop Med Hyg 79:275-282.
6. Enria DA, Briggiler AM, Sánchez Z. 2008. Treatment of Argentine hemorrhagic fever. Antiviral Res 78:132-139. http://dx.doi.org/10.1016/j.antiviral.2007.10.010.
7. Laguens RM, Avila MM, Samoilovich SR, Weissenbacher MC, Laguens RP. 1983. Pathogenicity of an attenuated strain (XJCl3) of Junin virus. Intervirology 20:195-201. http://dx.doi.org/10.1159/000149392.
8. Kenyon RH, Green DE, Eddy GA, Peters CJ. 1986. Treatment of Junin virus-infected guinea pigs with immune serum: development of late neurological disease. J Med Virol 20:207-218. http://dx.doi.org/10.1002/jmv.1890200303.
9. Enria DA, de Damilano AJ, Briggiler AM, Ambrosio AM, Fernandez NJ, Feuillade MR, Maiztegui JI. 1985. Late neurologic syndrome in patients with Argentinian hemorrhagic fever treated with immune plasma. Medicina (B Aires) 45:615-620. (In Spanish.).
10. Maiztegui JI, Fernandez NJ, de Damilano AJ. 1979. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet ii:1216-1217.
11. Buchmeier MJ, de la Torre JC, Peters CJ. 2013. Arenaviridae, p 1283-1303. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
12. Martínez-Sobrido L, Emonet S, Giannakas P, Cubitt B, García-Sastre A, de la Torre JC. 2009. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 83:11330-11340. http://dx.doi.org/10.1128/JVI.00763-09.
13. Martínez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC. 2007. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81:12696-12703. http://dx.doi.org/10.1128/JVI.00882-07.
14. Martínez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80:9192-9199. http://dx.doi.org/10.1128/JVI.00555-06.
15. Eckerle LD, Becker MM, Halpin RA, Li K, Venter E, Lu X, Scherbakova S, Graham RL, Baric RS, Stockwell TB, Spiro DJ, Denison MR. 2010. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog 6:e1000896. http://dx.doi.org/10.1371/journal.ppat.1000896.
16. Qi X, Lan S, Wang W, Schelde LM, Dong H, Wallat GD, Ly H, Liang Y, Dong C. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779-783. http://dx.doi.org/10.1038/nature09605.
17. Borden KL, Campbell Dwyer EJ, Salvato MS. 1998. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72:758-766.
18. Djavani M, Rodas J, Lukashevich IS, Horejsh D, Pandolfi PP, Borden KL, Salvato MS. 2001. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol 75:6204-6208. http://dx.doi.org/10.1128/JVI.75.13.6204-6208.2001.
19. Campbell Dwyer EJ, Lai H, MacDonald RC, Salvato MS, Borden KL. 2000. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J Virol 74:3293-3300. http://dx.doi.org/10.1128/JVI.74.7.3293-3300.2000.
20. Volpon L, Osborne MJ, Capul AA, de la Torre JC, Borden KLB. 2010. Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E. Proc Natl Acad Sci U S A 107:5441-5446. http://dx.doi.org/10.1073/pnas.0909877107.
21. Albariño CG, Bird BH, Chakrabarti AK, Dodd KA, Flint M, Bergeron É, White DM, Nichol ST. 2011. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J Virol 85:10404-10408. http://dx.doi.org/10.1128/JVI.00856-11.
22. Droniou-Bonzom ME, Reignier T, Oldenburg JE, Cox AU, Exline CM, Rathbun JY, Cannon PM. 2011. Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP. J Virol 85:13457-13462. http://dx.doi.org/10.1128/JVI.05616-11.
23. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. 7 February 2007, posting date. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96. http://dx.doi.org/10.1038/nature05539.
24. Flanagan ML, Oldenburg J, Reignier T, Holt N, Hamilton GA, Martin VK, Cannon PM. 2008. New World clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and-independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1. J Virol 82:938-948. http://dx.doi.org/10.1128/JVI.01397-07.
25. Emonet SF, Seregin AV, Yun NE, Poussard AL, Walker AG, de la Torre JC, Paessler S. 2011. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and liveattenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J Virol 85:1473-1483. http://dx.doi.org/10.1128/JVI.02102-10.
26. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45.